Education
About Us
Working with TipRanks
Follow Us
Zhengye Biotechnology Holding Ltd. (ZYBT)
NASDAQ:ZYBT
ZYBT Stock Chart & Stats
$1.85
--
Market closed
$1.85
--
Day’s Range― - ―
52-Week Range$1.40 - $14.30
Previous CloseN/A
VolumeN/A
Average Volume (3M)871.70K
Market Cap
$87.67M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.71
Next Earnings
Jul 03, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding47,391,376
10 Day Avg. Volume198,467
30 Day Avg. Volume871,704
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Zhengye Biotechnology Holding Ltd. News
ZYBT FAQ
What was Zhengye Biotechnology Holding Ltd.’s price range in the past 12 months?
Zhengye Biotechnology Holding Ltd. lowest stock price was $1.40 and its highest was $14.30 in the past 12 months.
What is Zhengye Biotechnology Holding Ltd.’s market cap?
Zhengye Biotechnology Holding Ltd.’s market cap is $87.67M.
When is Zhengye Biotechnology Holding Ltd.’s upcoming earnings report date?
Zhengye Biotechnology Holding Ltd.’s upcoming earnings report date is Jul 03, 2025 which is 172 days ago.
How were Zhengye Biotechnology Holding Ltd.’s earnings last quarter?
Zhengye Biotechnology Holding Ltd. released its earnings results on Jul 03, 2025. The company reported -$0.063 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.063.
Is Zhengye Biotechnology Holding Ltd. overvalued?
According to Wall Street analysts Zhengye Biotechnology Holding Ltd.’s price is currently Overvalued.
Does Zhengye Biotechnology Holding Ltd. pay dividends?
Zhengye Biotechnology Holding Ltd. does not currently pay dividends.
What is Zhengye Biotechnology Holding Ltd.’s EPS estimate?
Zhengye Biotechnology Holding Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zhengye Biotechnology Holding Ltd. have?
Zhengye Biotechnology Holding Ltd. has 47,391,376 shares outstanding.
What happened to Zhengye Biotechnology Holding Ltd.’s price movement after its last earnings report?
Zhengye Biotechnology Holding Ltd. reported an EPS of -$0.063 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.196%.
Which hedge fund is a major shareholder of Zhengye Biotechnology Holding Ltd.?
Currently, no hedge funds are holding shares in ZYBT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Zhengye Biotechnology Holding Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
4.06%
Trailing 12-Months
Asset Growth
-4.13%
Trailing 12-Months
Company Description
Zhengye Biotechnology Holding Ltd.
Zhengye Biotechnology Holding Ltd. (ZYBT) is a biotechnology company focused on the development and commercialization of innovative biopharmaceutical products. The company operates primarily in the fields of genetic engineering and molecular biology, specializing in the research and production of advanced therapeutics and diagnostic tools. ZYBT aims to address unmet medical needs through its core offerings, which include biopharmaceuticals, molecular diagnostics, and research services for various healthcare sectors.
Technical Analysis
China Pharma Holdings
―
China SXT Pharmaceuticals
―
Qilian International Holding Group Limited
―
Universe Pharmaceuticals
―
Shuttle Pharmaceuticals Holdings, Inc.
―
Ownership Overview
―
Insiders
0.06% Mutual Funds
0.05% Other Institutional Investors
99.82% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---